|
FR2092703A1
(en)
*
|
1970-06-10 |
1972-01-28 |
Delalande Sa |
2-(1-pyrrolidinocarbonylmethyl-piperazin-4-yl) ethyl - 3,4,5-trimethoxy benzoate - having hypotensive and adrenolytic active
|
|
FR2092902A1
(en)
*
|
1970-06-30 |
1972-01-28 |
Delalande Sa |
Substd propiophenone - beta (pyrrolidino carbonylmethyl)-1'-piperazin propiophenones, analgesics, hypotensives adrenolytics, noradrenolytic
|
|
FR2278340A1
(fr)
*
|
1974-07-17 |
1976-02-13 |
Delalande Sa |
Nouveau derive de la n-(trimethoxy-3,4,5 cinnamoyl) piperazine, ses sels d'addition d'acides, son procede de preparation et son application en therapeutique
|
|
GB1473262A
(en)
*
|
1974-11-20 |
1977-05-11 |
Delalande Sa |
Derivatives of n-3,4,5-trimethoxy cinnamoyl-piperazine their process of preparation and their therapeutic application
|
|
GR71991B
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1980-01-21 |
1983-08-26 |
Delalande Sa |
|
|
JPS5888370A
(ja)
*
|
1981-11-19 |
1983-05-26 |
Hokuriku Seiyaku Co Ltd |
１−（３，４，５−トリメトキシシンナモイル）−４−アミノカルボニルエチル置換ピペラジン及びホモピペラジン誘導体、及びその製造方法
|
|
IT1151104B
(it)
*
|
1982-02-04 |
1986-12-17 |
Delalande Sa |
Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici
|
|
FR2522325B1
(fr)
*
|
1982-02-26 |
1985-08-09 |
Delalande Sa |
Nouveaux derives aryliques de la piperazine, de l'homopiperazine et de n,n'-dialkyl diamino-1,2 ethane, leur procede de preparation et leur application en therapeutique
|
|
FR2552762B1
(fr)
*
|
1983-09-30 |
1986-07-25 |
Delalande Sa |
Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique
|
|
JPS6172773A
(ja)
*
|
1984-09-17 |
1986-04-14 |
Terumo Corp |
ピペラジン誘導体およびこれを含有する血管拡張剤
|
|
US6011035A
(en)
*
|
1998-06-30 |
2000-01-04 |
Neuromed Technologies Inc. |
Calcium channel blockers
|
|
KR100668539B1
(ko)
|
2002-08-19 |
2007-01-16 |
화이자 프로덕츠 인크. |
과증식성 질환에 대한 조합요법
|
|
US20050037063A1
(en)
*
|
2003-07-21 |
2005-02-17 |
Bolton Anthony E. |
Combined therapies
|
|
US20060063803A1
(en)
*
|
2004-09-23 |
2006-03-23 |
Pfizer Inc |
4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
|
US8383660B2
(en)
|
2006-03-10 |
2013-02-26 |
Pfizer Inc. |
Dibenzyl amine compounds and derivatives
|
|
US7919506B2
(en)
|
2006-03-10 |
2011-04-05 |
Pfizer Inc. |
Dibenzyl amine compounds and derivatives
|
|
EP2094643B1
(en)
|
2006-12-01 |
2012-02-29 |
Bristol-Myers Squibb Company |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
|
CN101754957A
(zh)
|
2007-07-19 |
2010-06-23 |
弗·哈夫曼-拉罗切有限公司 |
新的杂环基化合物和它们作为趋化因子拮抗剂的用途
|
|
CN101260092B
(zh)
*
|
2008-04-14 |
2011-07-20 |
罗军 |
马来酸桂哌齐特的制备方法
|
|
CN101723918B
(zh)
*
|
2008-10-24 |
2011-08-31 |
重庆医科大学医药研究所 |
马来酸桂哌齐特的制备工艺
|
|
CN101531643B
(zh)
*
|
2009-04-13 |
2012-11-14 |
上海理奥生物医药科技有限责任公司 |
一种改进的马来酸桂哌齐特的合成方法
|
|
CN102229583B
(zh)
*
|
2011-05-13 |
2013-11-27 |
江苏神龙药业有限公司 |
一种桂哌齐特的合成方法
|
|
CN103664830A
(zh)
*
|
2012-09-05 |
2014-03-26 |
凌沛学 |
一种马来酸桂哌齐特改进的合成方法
|
|
CN103896878B
(zh)
*
|
2012-12-26 |
2018-02-09 |
江苏万邦生化医药股份有限公司 |
一种桂哌齐特的纯化脱色方法
|
|
CN103245734A
(zh)
*
|
2013-01-18 |
2013-08-14 |
沈阳亿灵医药科技有限公司 |
一组控制马来酸桂哌齐特质量的组合物
|
|
MX2015014666A
(es)
|
2013-04-17 |
2016-03-01 |
Pfizer |
Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
|
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
|
EP3911648B1
(en)
|
2019-01-18 |
2024-10-23 |
Astrazeneca AB |
6'-[[(1s,3s)-3-[[5-(difluoromethoxy)-2-pyrimidinyl]amino]cyclopentyl]amino][1(2h),3'-bipyridin]-2-one as pcsk9 inhibitor and methods of use thereof
|